Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Billerud’s Annual and Sustainability Report 2023

Billerud publishes its Annual and Sustainability Report for 2023.The Annual and Sustainability Report for 2023 is from today available on the company’s website and is attached to this press release. On Billerud’s website, there is also a digital short version of the Annual and Sustainability Report, please see https://www.billerud.com/2023-in-briefFor further information, contact:Lena Schattauer, Director Investor Relations, +46 8 553 335 10, ir@billerud.comUlrika Wedberg, EVP Sustainability & Public Affairs, +46 8 553 336 43, sustainability@billerud.comThis information is

Resolutions of Konecranes Plc’s Annual General Meeting of shareholders

KONECRANES PLC STOCK EXCHANGE RELEASE MARCH 27, 2024 at 12:30 PM EET   Resolutions of Konecranes Plc’s Annual General Meeting of shareholders   The Annual General Meeting of Konecranes Plc ("Konecranes" or the "Company") was held today, Wednesday 27 March 2024 at 10.00 am EET at Hyvinkääsali (address: Kauppatori 1, FI-05800 Hyvinkää, Finland).   The meeting approved the Company's annual accounts for the fiscal year 2023, discharged the members of the Board of Directors and the CEO from liability, and approved all proposals made by the Board of Directors and its committees

Change of Certified Adviser

COMPANY ANNOUNCEMENT NO. 96LED iBond International A/S has entered into an agreement with HC Andersen Capital, an approved certified adviser by Nasdaq First North Growth Market Denmark. The reason for the change has been, among other things, that HC Andersen Capital is a Danish-based certified adviser and that LED iBond wants a greater focus on Danish investors and investor communities. Martin Løbel, CEO of LED iBond international comments:  We would like to thank Västra Hamnen for being our Certified Adviser for four years since the IPO on Nasdaq First North Growth Market in 2020.

The place to be for developing and testing new medicines and technologies

Gothenburg has a lot of knowledge and capabilities within life science. But where Sweden’s second city really stands out is its collaborative approach and capacity to get things done, explains Iris Öhrn, investment advisor for life science at Business Region Göteborg.For more than a decade she’s been spreading word of the good things happening here and supporting companies and investors who want to become part it.  Gothenburg has a lot going on. And the ecosystem is experiencing rapid growth. “We are very strong in a lot of important areas including advanced therapies, regenerative

Circio Holding ASA: Registration of share capital increase following conversion of convertible bonds

Oslo, 27 March 2024: Reference is made to the stock exchange announcement by Circio Holding ASA (OSE:CRNA) (“CIRCIO” or the “Company“) on 21 March 2024, regarding the requested conversion of convertible bonds by Atlas Special Opportunities, LLC. The share capital increase has now been registered with the Norwegian Register of Business Enterprises (Nw. Foretaksregisteret). The Company’s new share capital is NOK 4,865,976.00 divided into 8,109,960 shares, each with a nominal value of NOK 0.60.

Slättö announces investment from Ares Management

Slättö and Ares Management Real Estate Secondaries funds (“Ares”) have agreed to support the recapitalization of a market-leading light-industrial and logistics portfolio, which is managed by Slättö. The portfolio comprises 28 assets with value concentrated in the Stockholm and Helsinki metropolitan areas.“We are delighted to work with Ares as a transaction partner,” says Jonas Andersson, Deputy Managing Partner at Slättö. “This deal is another testament to Slättö’s ability to attract the most sophisticated capital to our funds and conviction segments, using our unique capabilities to build

SyntheticMR receives FDA 510(k) clearance for their next Generation Solution SyMRI 3D

SyntheticMR announced today that their next-generation imaging solution with isotropic resolution, SyMRI 3D, has received FDA 510(k) clearance for clinical use in the United States. SyntheticMR is proud to announce that its next-generation imaging solution, SyMRI 3D, has received FDA 510(k) clearance for clinical use in the United States. This milestone marks a significant advancement in quantitative MRI technology, offering unprecedented resolution and accuracy in brain imaging. "We are thrilled to receive 510(k) clearance for SyMRI 3D," says Ulrik Harrysson, CEO at

NIB finances renewable energy supply for green ammonia production in Lithuania

The Nordic Investment Bank (NIB) and UAB LT Energija have signed a EUR 100 million loan for a 264 MW wind farm in Pagėgiai, Lithuania. The European Union supports EUR 43.5 million of the loan under the NIB's InvestEU Framework Operation on Clean Energy Transition.The 21-year maturity loan will finance the construction of 40 wind turbines, as well as the associated civil and electrical infrastructure. The Pagėgiai wind farm will significantly increase energy generation capacity in Lithuania, which currently imports the majority of its power consumption. It will generate an estimated 602

Minutes from the Annual General Meeting in Cessatech A/S

Cessatech A/S, CVR no. 41293055 (“Cessatech” or the “Company”) held its Annual General Meeting on Wednesday 27 March 2023 at 09:00 (CET) at the Company's address Kanonbådsvej 2, 1437 København K.The agenda for the general meeting was as follows: 1. ELECTION OF CHAIRMAN OF THE MEETING 1. Mikkel Rostock-Jensen was elected chairman of the meeting. The chairman of the meeting ascertained that none of the shareholders objected to the legality of the annual general meeting and announced that the annual general meeting had been duly convened and was legal and competent in terms of all

Report from the extraordinary general meeting of Biokraft International AB (publ)

Stockholm, 27 March 2024Biokraft International AB (publ), reg.no 556528-4733, has today held an extraordinary general meeting, at which the following was resolved. The meeting was conducted with the possibility to participate through postal voting.   Resolutions to amend the Articles of Association The extraordinary general meeting resolved, in accordance with the Board of Directors' proposal, to amend the company’s Articles of Association, whereby the limits of the share capital are changed to a minimum of SEK 87,000,000 and a maximum of SEK 348,000,000 and the number of shares to

MyfirstApp Sweden: CEO Update on Vision and the Future of the Company

MyfirstApp Sweden offers a range of digital services, primarily consisting of digital applications tailored for children. The solutions are used by numerous preschools/schools where the apps are adapted with various developmental levels for learning and personal development. The apps go by different names and cover areas such as basic mathematics and cognitive abilities.In early March 2024, the company's CEO, Jesper Nord, was interviewed by Per Stolt from Dagens Börs, read the full interview here  (in Swedish). Today, the company

Notice to the annual general meeting of ADDvise Group AB (publ)

ADDvise Group AB (publ), reg. no. 556363–2115, hereby convenes the annual general meeting on 3 May 2024 at 10:00 CEST at Grev Turegatan 30 in Stockholm. Entrance and registration start at 09.30 CEST. NOTIFICATIONShareholders wishing to attend the annual general meeting must: i)          be registered in the share register kept by Euroclear Sweden AB on the record date 24 April 2024, or, if the shareholder has had his/her shares registered in the name of a nominee, request that the nominee registers the shares for voting purposes in such time that the registration is completed no

The Swedish Medical Products Agency approves subgroup analysis in NextCell's ProTrans-Young study

NextCell Pharma AB ("NextCell" or the "Company") today announces that the Swedish Medical Products Agency has approved an application to conduct a subgroup analysis of the treatment effect of ProTrans in 30 adolescents in the age group 12-21 years, treated in the ProTrans-Young study. Principal Investigator Professor Per-Ola Carlsson and his team treated the last patient in the age group in February 2024. The approval for the subgroup analysis by the Swedish Medical Products Agency means that the primary efficacy endpoint readout is available after 12 months. The primary efficacy endpoint is

Hamlet BioPharma arranges a new series of digital events

Hamlet BioPharma invites you to a series of events aiming to provide insights into the project portfolio’s strong development pipeline, the advanced technologies and the committed and highly competent group of individuals that moves the company forward.   These events will be held on Zoom and open to the public, reflecting the company's commitment to transparency and engagement with the community. The first three presentations are scheduled for April 9th, May 8th, and June 12th.   The presentations represent an opportunity for participants to gain insights into our drug

Decisions of the Annual General Meeting of CapMan Plc

CapMan Plc Stock Exchange Release / Decisions of the General Meeting 27 March 2024 at 11.10 a.m. EET Decisions of the Annual General Meeting of CapMan Plc The Annual General Meeting (AGM) of CapMan Plc was held today in Helsinki. The AGM approved the annual accounts for the financial year 2023, approved the company’s remuneration report and discharged the company’s directors from liability. The AGM approved all the proposals of the Board of Directors and the Shareholders’ Nomination Board to the AGM. Use of the profit shown on the balance sheet and the payment of dividend The

Securitas publishes Annual and Sustainability Report for 2023

The Annual and Sustainability Report 2023 is now available and can be read and downloaded at Securitas website: www.securitas.com/en/investors/financial-reports-and-presentations/The Swedish Annual and Sustainability Report 2023 is also available on Securitas’ website in European Single Electronic Format (ESEF). As we strive to reduce the climate impact, we do not print the Annual and Sustainability Report.   Further information: Investors: Micaela Sjökvist, Vice President, Investor Relations+46 76 116 7443, micaela.sjokvist@securitas.com

Notice of the Annual General Meeting of Kamux Corporation

Kamux Corporation, Stock exchange release, 27.3.2024 at 11:00 Notice of the Annual General Meeting of Kamux Corporation Notice is given to the shareholders of Kamux Corporation (“Kamux” or the “company”) to the Annual General Meeting to be held on Thursday, April 18, 2024, at 1:00 p.m. (EEST). The Annual General Meeting will be held at Clarion Hotel Helsinki, at the address of Tyynenmerenkatu 2, 00220 Helsinki, Finland. The reception of registrants and the distribution of ballot papers will begin at 12:00 p.m. (EEST). Shareholders of Kamux may also exercise their voting rights by

Medicover’s Annual Report for 2023 is published

Medicover’s annual report including sustainability report for 2023 has today been published and is now available on the company’s website medicover.com . The annual report is also attached to this press release. For further information, please contact:Hanna Bjellquist, Head of Investor Relations+46 703 033 272hanna.bjellquist@medicover.com This information is information that Medicover AB (publ) is obliged to make public pursuant to the Securities Markets Act. The information was submitted for publication

Increased capacity in Finland for locally produced Lambi Home Towel household towel sheets

PRESS RELEASE 27.03.2024 AT 10.50 Lambi Home Towel household towels in sheet format are a practical everyday tool for making cleanliness even more convenient. One Lambi Home Towel package holds the same amount of paper as two rolls of kitchen paper in a compact space. An investment in a new packaging line at Metsä Group's Mänttä tissue paper mill, which was commissioned in late 2023 to improve the efficiency of the hand towel line, has enabled an increase in the capacity for the production of Lambi Home Towel sheets. Household towel sheets make everyday life easier, bringing even more

SCAP and Zwipe partner to bring biometric access cards in France

SCAP becomes a distributor for Zwipe and creates the first starter pack in French for Zwipe Access, the biometric Access control cardOSLO, NORWAY and VAULX EN VELIN March 27, 2024 – Zwipe A.S., a company listed on the stock exchanges of Oslo and Stockholm, a pioneer and world leader in the development of biometric technology on cards for identification, access control and payment, has teamed up with SCAP, the leading distributor of access control cards and readers in France,  focusing on providing advanced security RFID solutions, to introduce the innovative "biometric system-on-card" to

Fazer is one of the local partners for the 2024 MICHELIN Guide Ceremony Nordic Countries – The Nordic MICHELIN Stars will be awarded in May in Helsinki

The annual MICHELIN Guide Ceremony awarding the Nordic restaurants is held in Helsinki May 27[th]. Like last year, Fazer is one of the Ceremony’s local partners. Fazer, the food experience company, will collaborate with the City of Helsinki and be widely present at both the cocktail dinner as well as other stakeholder events held in connection with the MICHELIN Guide Ceremony.“The MICHELIN Guide is a highly respected player in the food industry. By cooperating with the MICHELIN Guide in the frame of its Nordic Countries Ceremony, we are very happy to be able to offer high-quality Nordic

BioStock: Spago Nanomedical’s CEO: “huge commercial opportunities are unfolding”

Last week we saw the USD 2 billion buyout of Fusion Pharmaceuticals by AstraZeneca to accelerate the development of next-generation radioconjugates to treat cancer. The deal showcases rising interest in the field of radiopharmaceuticals. BioStock got in touch with Mats Hansen, CEO of Swedish radiopharma company Spago Nanomedical to get his take on the deal and where Spago is in its development of lead programme Tumorad.Read the article at biostock.se: Spago Nanomedical’s CEO: “huge commercial opportunities are unfolding” - BioStock 

Notification of managers’ and closely related parties’ transactions with Dampskibsselskabet NORDEN A/S’ shares in connection with share buy-back program

ANNOUNCEMENT NO. 75 – 27 MARTS 2024   In connection with the announced share buy-back program in NORDEN, A/S Motortramp continuously sells shares pro rata and the market is to be informed accordingly – see the attached file and announcements nos. 30/24 and 31/24.   Kind regards, Dampskibsselskabet NORDEN A/S   Martin Badsted CFO     For further information: Stig Frederiksen, Head of Communications & Investor Relations, tel.: +45 32 71 08 55, e-mail: sfr@norden.com

There are no items matching the current filter
There are no more items matching the current filter
Back to top